Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07142096

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Université Catholique de Louvain · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to validate biomarkers in blood and tumor biopsy in patients with Triple Negative Breast Cancer, after a course of MitoQ treatment

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMitoQ (mitoquinol mesylate)Dietary supplement course before surgery or chemo/radio-therapy

Timeline

Start date
2025-07-20
Primary completion
2026-07-20
Completion
2026-07-20
First posted
2025-08-26
Last updated
2025-08-26

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT07142096. Inclusion in this directory is not an endorsement.

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer (NCT07142096) · Clinical Trials Directory